Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Gesztelyi

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Neurological Research|December 27, 2011
Different effect of hyperglycemia on stroke outcome in non-diabetic and diabetic patients--a cohort studyJudit Zsuga, Rudolf Gesztelyi, Adam Kemeny-Beke, et al.
International Journal of Molecular Sciences|September 26, 2018
Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular DiseaseDaniel Priksz, Mariann Bombicz, Balazs Varga, et al.
BMC Pulmonary Medicine|August 26, 2024
Association of monoaminergic gene polymorphisms in chronic inflammatory pulmonary disease patients with successful smoking cessationAngela Mikaczo, Csaba Papp, Tamas Erdei, et al.
Frontiers in Pharmacology|May 17, 2024
The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptorIgnac Ovari, Gabor Viczjan, Tamas Erdei, et al.
Ocular Immunology and Inflammation|November 17, 2018
Corneal Involvement of Patients with Polymyositis and DermatomyositisZoltan Griger, Katalin Danko, Levente Bodoki, et al.
Molecules (Basel, Switzerland)|June 20, 2019
An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A<sub>1</sub> Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig AtriumAdrienn Monika Szabo, Tamas Erdei, Gabor Viczjan, et al.
Journal of Pharmacological Sciences|December 4, 2003
Comparative pharmacological studies on the A2 adenosine receptor agonist 5'-n-ethyl-carboxamidoadenosine and its F19 isotope labelled derivativeBálint Rubovszky, A József Szentmiklósi, Teréz Márián, et al.
General Physiology and Biophysics|November 2, 2013
Approximation of A1 adenosine receptor reserve appertaining to the direct negative inotropic effect of adenosine in hyperthyroid guinea pig left atriaKrisztian Pak, Csaba Papp, Zoltan Galajda, et al.
International Journal of Molecular Sciences|September 20, 2013
Adverse impact of diet-induced hypercholesterolemia on cardiovascular tissue homeostasis in a rabbit model: time-dependent changes in cardiac parametersAttila Kertész, Mariann Bombicz, Daniel Priksz, et al.
Metabolism: Clinical and Experimental|February 13, 2007
Dimethylarginines at the crossroad of insulin resistance and atherosclerosisJudit Zsuga, János Török, Mária T Magyar, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Neurological Research|December 27, 2011
Different effect of hyperglycemia on stroke outcome in non-diabetic and diabetic patients--a cohort studyJudit Zsuga, Rudolf Gesztelyi, Adam Kemeny-Beke, et al.
International Journal of Molecular Sciences|September 26, 2018
Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular DiseaseDaniel Priksz, Mariann Bombicz, Balazs Varga, et al.
BMC Pulmonary Medicine|August 26, 2024
Association of monoaminergic gene polymorphisms in chronic inflammatory pulmonary disease patients with successful smoking cessationAngela Mikaczo, Csaba Papp, Tamas Erdei, et al.
Frontiers in Pharmacology|May 17, 2024
The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptorIgnac Ovari, Gabor Viczjan, Tamas Erdei, et al.
Ocular Immunology and Inflammation|November 17, 2018
Corneal Involvement of Patients with Polymyositis and DermatomyositisZoltan Griger, Katalin Danko, Levente Bodoki, et al.
Molecules (Basel, Switzerland)|June 20, 2019
An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A<sub>1</sub> Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig AtriumAdrienn Monika Szabo, Tamas Erdei, Gabor Viczjan, et al.
Journal of Pharmacological Sciences|December 4, 2003
Comparative pharmacological studies on the A2 adenosine receptor agonist 5'-n-ethyl-carboxamidoadenosine and its F19 isotope labelled derivativeBálint Rubovszky, A József Szentmiklósi, Teréz Márián, et al.
General Physiology and Biophysics|November 2, 2013
Approximation of A1 adenosine receptor reserve appertaining to the direct negative inotropic effect of adenosine in hyperthyroid guinea pig left atriaKrisztian Pak, Csaba Papp, Zoltan Galajda, et al.
International Journal of Molecular Sciences|September 20, 2013
Adverse impact of diet-induced hypercholesterolemia on cardiovascular tissue homeostasis in a rabbit model: time-dependent changes in cardiac parametersAttila Kertész, Mariann Bombicz, Daniel Priksz, et al.
Metabolism: Clinical and Experimental|February 13, 2007
Dimethylarginines at the crossroad of insulin resistance and atherosclerosisJudit Zsuga, János Török, Mária T Magyar, et al.
Pageof 12